Zecotek Photonics - die Aktie 2008 (Seite 742)
eröffnet am 29.11.07 14:46:26 von
neuester Beitrag 25.04.24 11:43:24 von
neuester Beitrag 25.04.24 11:43:24 von
Beiträge: 29.056
ID: 1.135.811
ID: 1.135.811
Aufrufe heute: 0
Gesamt: 2.793.809
Gesamt: 2.793.809
Aktive User: 0
ISIN: CA98921P1045 · WKN: A0M8QZ · Symbol: ZMSPF
0,0000
USD
0,00 %
0,0000 USD
Letzter Kurs 23.03.24 Nasdaq OTC
Werte aus der Branche Sonstige Technologie
Wertpapier | Kurs | Perf. % |
---|---|---|
1,6800 | +17,48 | |
2,0000 | +14,29 | |
0,7500 | +11,11 | |
0,5150 | +9,57 | |
1,0000 | +7,64 |
Wertpapier | Kurs | Perf. % |
---|---|---|
3,1800 | -7,56 | |
2,0700 | -8,41 | |
1,1900 | -9,16 | |
0,5160 | -9,47 | |
18,950 | -10,61 |
Beitrag zu dieser Diskussion schreiben
Antwort auf Beitrag Nr.: 48.121.139 von Ludebaer am 24.10.14 09:32:57Das einzige was der Laden verkauft sind Aktien. Ist auch ein Geschäftsmodell.
Gruß
Miri
Gruß
Miri
quelle: http://www.zecotek.com/EN/capital_structure/
Capital Structure
Capital structure as at April 1, 2014
Issued & Outstanding Common Shares
98,006,520
Common Share Purchase Warrants Outstanding
Exercise Price $0.55, Expiry 08-Feb-2015
3,370,000
Exercise Price $0.55, Expiry 17-Feb-2015
1,051,320
Exercise Price $0.50, Expiry 12-Oct-2014
800,000
Exercise Price $0.50, Expiry 03-Dec-2014
472,222
Exercise Price $0.50, Expiry 10-Apr-2015
1,364,443
Exercise Price $0.50, Expiry 07-Jun-2015
450,056
Exercise Price $0.75, Expiry 05-Sep-2015
2,983,469
Stock Options
16,050,000
Agent Warrants
Exercise Price $0.50, Expiry 12-Oct-2015
112,000
Exercise Price $0.50, Expiry 03-Dec-2015
46,666
Exercise Price $0.50, Expiry 10-Apr-2015
184,021
Exercise Price $0.50, Expiry 07-Jun-2015
32'705
Exercise Price $0.75, Expiry 05-Sep-2015
403,516
Common Shares Fully Diluted
125,326,938
+ was durch die neue ke noch dazu kommt!
inzwischen eine beachtliche menge!!!
Capital Structure
Capital structure as at April 1, 2014
Issued & Outstanding Common Shares
98,006,520
Common Share Purchase Warrants Outstanding
Exercise Price $0.55, Expiry 08-Feb-2015
3,370,000
Exercise Price $0.55, Expiry 17-Feb-2015
1,051,320
Exercise Price $0.50, Expiry 12-Oct-2014
800,000
Exercise Price $0.50, Expiry 03-Dec-2014
472,222
Exercise Price $0.50, Expiry 10-Apr-2015
1,364,443
Exercise Price $0.50, Expiry 07-Jun-2015
450,056
Exercise Price $0.75, Expiry 05-Sep-2015
2,983,469
Stock Options
16,050,000
Agent Warrants
Exercise Price $0.50, Expiry 12-Oct-2015
112,000
Exercise Price $0.50, Expiry 03-Dec-2015
46,666
Exercise Price $0.50, Expiry 10-Apr-2015
184,021
Exercise Price $0.50, Expiry 07-Jun-2015
32'705
Exercise Price $0.75, Expiry 05-Sep-2015
403,516
Common Shares Fully Diluted
125,326,938
+ was durch die neue ke noch dazu kommt!
inzwischen eine beachtliche menge!!!
Antwort auf Beitrag Nr.: 48.115.991 von Ludebaer am 23.10.14 17:08:25Klar, Zerrouks Gehalt kann weiter bezahlt werden
Gruß
Miri
Gruß
Miri
Zitat von Ludebaer: man kann aus der ke sicher wieder was positives gewinnen.
Antwort auf Beitrag Nr.: 48.115.430 von harry-art3 am 23.10.14 16:34:02
man kann aus der ke sicher wieder was positives gewinnen.
man kann aus der ke sicher wieder was positives gewinnen.
Jetzt müsste aber wirklich dem letzten Verschwörungstheoretiker ein Kronleuchter aufgehen!
war ja klar!
ke zu schweinepreisen. verwässerung bis der arzt kommt.
ist anscheinend vom operativen geschäft keine kohle in sicht in nächster zeit.
ke zu schweinepreisen. verwässerung bis der arzt kommt.
ist anscheinend vom operativen geschäft keine kohle in sicht in nächster zeit.
Aha:
SINGAPORE, Oct. 23, 2014 /CNW/ - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), (the "Company") a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, today announced that it has engaged Maison Placements Canada Inc. ("Maison") of Toronto, to conduct a best efforts brokered private placement offering of equity units of up to $2.5 million through issue of up to 7,142,857 units of the Company (each, a "Unit") at a price of $0.35 per Unit.
Each Unit will consist of one common share of the Company ("Common Share") and one common share purchase warrant. Each common share purchase warrant entitles the holder to acquire one additional Common Share at an exercise price of $0.50 per Common Share for a period of 24 months after the date the private placement closes. The Common Shares and warrants issued pursuant to the private placement will be subject to a four-month hold period.
Pursuant to the financing, the Company will pay to Maison 7% of the proceeds of the sale of the Units and issue non-transferable agent's warrants to purchase Common Shares equal in number to 7% of the Units sold to investors found by Maison, at an exercise price of $0.50 per share for a period of 24 months.
Net proceeds from the funds raised will be used for general working capital and to commercialize the Company`s portfolio of photonic technologies. The financing remains subject to the approval of the TSX Venture Exchange.
About Zecotek
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing high-performance scintillation crystals, photo detectors, positron emission tomography scanning technologies, 3D auto-stereoscopic displays, and lasers for applications in medical, high-tech and industrial sectors. Founded in 2004, Zecotek operates three divisions: Imaging Systems, Laser Systems and 3D Display Systems with labs located in Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on building shareholder value by commercializing over 50 patented and patent pending novel photonic technologies directly and through strategic alliances and joint ventures with leading industry partners including Hamamatsu Photonics (Japan), the European Organization for Nuclear Research (Switzerland), Beijing Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems (South Korea), the University of Washington (United States), and National NanoFab Center (South Korea). For more information visit www.zecotek.com, follow @zecotek on Twitter and "like" us in Facebook at www.facebook.com/zecotek.
This press release may contain forward-looking statements that are based on management's expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.
SOURCE Zecotek Photonics Inc.
Zecotek Photonics Inc., Michael Minder, T: (604) 783-8291, ir@zecotek.comCopyright CNW Group 2014
Canada Newswire
October 23, 2014 - 8:30 AM EDT
Read more at http://www.stockhouse.com/news/press-releases/2014/10/23/zec…
SINGAPORE, Oct. 23, 2014 /CNW/ - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), (the "Company") a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, today announced that it has engaged Maison Placements Canada Inc. ("Maison") of Toronto, to conduct a best efforts brokered private placement offering of equity units of up to $2.5 million through issue of up to 7,142,857 units of the Company (each, a "Unit") at a price of $0.35 per Unit.
Each Unit will consist of one common share of the Company ("Common Share") and one common share purchase warrant. Each common share purchase warrant entitles the holder to acquire one additional Common Share at an exercise price of $0.50 per Common Share for a period of 24 months after the date the private placement closes. The Common Shares and warrants issued pursuant to the private placement will be subject to a four-month hold period.
Pursuant to the financing, the Company will pay to Maison 7% of the proceeds of the sale of the Units and issue non-transferable agent's warrants to purchase Common Shares equal in number to 7% of the Units sold to investors found by Maison, at an exercise price of $0.50 per share for a period of 24 months.
Net proceeds from the funds raised will be used for general working capital and to commercialize the Company`s portfolio of photonic technologies. The financing remains subject to the approval of the TSX Venture Exchange.
About Zecotek
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing high-performance scintillation crystals, photo detectors, positron emission tomography scanning technologies, 3D auto-stereoscopic displays, and lasers for applications in medical, high-tech and industrial sectors. Founded in 2004, Zecotek operates three divisions: Imaging Systems, Laser Systems and 3D Display Systems with labs located in Canada, Korea, Russia, Singapore and U.S.A. The management team is focused on building shareholder value by commercializing over 50 patented and patent pending novel photonic technologies directly and through strategic alliances and joint ventures with leading industry partners including Hamamatsu Photonics (Japan), the European Organization for Nuclear Research (Switzerland), Beijing Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems (South Korea), the University of Washington (United States), and National NanoFab Center (South Korea). For more information visit www.zecotek.com, follow @zecotek on Twitter and "like" us in Facebook at www.facebook.com/zecotek.
This press release may contain forward-looking statements that are based on management's expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.
SOURCE Zecotek Photonics Inc.
Zecotek Photonics Inc., Michael Minder, T: (604) 783-8291, ir@zecotek.comCopyright CNW Group 2014
Canada Newswire
October 23, 2014 - 8:30 AM EDT
Read more at http://www.stockhouse.com/news/press-releases/2014/10/23/zec…
Lieber Mod,
dann lösche bitte auch Beitrag 21.637, da dies jetzt eine Antwort auf ein gelöschtes Posting ist.
Mein Posting mit der Rangfolge der Verluste hatte sehr wohl einen Bezug zum Threadthema.
Und die Teilnahme ist ja freiwillig.
Gruß
Miri
dann lösche bitte auch Beitrag 21.637, da dies jetzt eine Antwort auf ein gelöschtes Posting ist.
Mein Posting mit der Rangfolge der Verluste hatte sehr wohl einen Bezug zum Threadthema.
Und die Teilnahme ist ja freiwillig.
Gruß
Miri
!
Dieser Beitrag wurde von CloudMOD moderiert. Grund: kein Bezug zum Threadthema